Table 3.
|
Outcomesa, aORb (95% CI) | |||
|
Office visits | HIV laboratory tests | HIV viral suppression | |
All patientsc | ||||
|
PPA | 1.66 (0.99-2.80) | —d | — |
|
Non-PPA | Reference | — | — |
Age 13-24 yearse | ||||
|
PPA | — | 2.85 (1.03-7.90) | 4.22 (1.28-13.89) |
|
Non-PPA | — | Reference | Reference |
Age 25-29 years | ||||
|
PPA | — | 1.86 (0.84-4.12) | 1.07 (0.46-2.50) |
|
Non-PPA | — | Reference | Reference |
Age 30-34 years | ||||
|
PPA | — | 0.54 (0.18-1.64) | 0.45 (0.11-1.75) |
|
Non-PPA | — | Reference | Reference |
aOutcomes are measured 6-12 months after baseline measure.
baOR: adjusted odds ratio.
cOverall model adjusted for age, sex at birth, race, newly diagnosed, out of care, and 6-12 months prebaseline measures.
dWhen modeling outcomes, all-patient models are not relevant when age acts as an effect modifier, and age-stratified models are not relevant when age does not act as an effect modifier.
eAge-stratified models adjusted for sex at birth, race, newly diagnosed, out of care, and 6-12 months prebaseline measures.